← All Sponsors
SPONSOR

Nir Peled

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: NSCLC (non-small Cell Lung Cancer)
NCT06667167 Phase 2
Recruiting

First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy

NSCLC (non-small Cell Lung Cancer)
Israel View Trial →